Ipamorelin IP10 10mg*10vials

Iparrelin IP10 (10mg x 10 vials) is the flagship, all-in-one version of the IP series of iparrelin growth hormone secretion peptides, a top-tier upgrade based on the IP2 and IP5 generations. IP10 utilizes full-spectrum saturated molecular optimization technology to maximize GHS-R1a receptor binding saturation, achieve excellent molecular anti-degradation stability, and possess peak pulsed growth hormone secretion activity. It inherits the series' core advantage of ultra-high selectivity, generating precise physiological growth hormone pulses without increasing cortisol or prolactin levels, completely avoiding non-specific hormone interference. Its ultra-high 10mg concentration makes it perfectly suited for applications such as ultra-high dose gradient limit studies, long-term, multi-cycle growth hormone axis intervention, deep body composition remodeling, and high-standard complex peptide synergistic mechanism validation. It is a core research material for cutting-edge endocrinology and high-threshold metabolism preclinical studies.

Product Functions and Research Value

In advanced laboratory studies, iparelin IP10 achieves saturated, robust, pulsed release of endogenous growth hormone (GH), perfectly mimicking the body's optimal natural hormone secretion rhythm. Compared to low-dose IP2 and medium-dose IP5, IP10 exhibits a more comprehensive downstream physiological phenotype and offers the greatest experimental discrimination and data stability. It is widely used in in-depth studies of lean muscle protein hypersynthesis, efficient deep lipolysis activation, advanced bone mineralization remodeling, and high-intensity tissue damage repair. Due to the absence of off-target hormone interference, it provides ultrapure signaling pathways for exploring extreme GH axis regulation, advanced anti-aging endocrine mechanisms, correction of severe metabolic imbalances, and high-dose peptide combination therapy regimens. IP10 stably outputs authoritative data with ultra-high precision and high reproducibility, perfectly meeting the stringent data requirements of cutting-edge scientific research.

Core Product Advantages

1. IP10 Ultimate All-Around Flagship Upgrade: Utilizing fully saturated molecular reconstruction technology, it surpasses IP2, IP5, and traditional iparrelin in all aspects of receptor affinity, molecular stability, and secretory potency. It is the highest-performing iteration in the entire IP series, possessing extremely high experimental phenotypic significance.

2. 100% High-Purity Selective GH Activation: Strictly targets the GHS-R1a single pathway, inducing physiological pulsatile GH release. It does not cause abnormal fluctuations in cortisol, prolactin, or other interfering hormones, ensuring an ultra-pure experimental background and reliable mechanistic conclusions.

3. 10mg Ultra-High Concentration Upper Limit: The industry's highest saturated concentration, with potency twice that of IP5 and five times that of IP2. It completely solves the problem of insufficient efficacy in low-dose and medium-dose versions, making it perfectly suitable for extreme dose gradient screening, ultra-long-term continuous modeling, and high-standard compound peptide research.

4. Pharmaceutical-Grade Ultimate Activity-Locking Process: Advanced aseptic vacuum fully-locked lyophilization process retains 100% of the inherent peptide activity. Each batch of products undergoes rigorous full-item HPLC purity testing and is equipped with a complete official Certificate of Account (COA). Impurity content is extremely low, with zero batch-to-batch variation. 5. High-end standardized aseptic packaging: Each box contains 10 vials, using integrated high-standard aseptic packaging, making it an ideal choice for cutting-edge research in high-end laboratories, key national scientific research projects, preclinical development of top-tier drugs, and large-scale global wholesale procurement.

--- Chinese Product Description (Research Compliance Version) Iparrelin IP10 10mg*10 vials is the flagship product of the Iparrelin IP series of growth hormone peptides, offering comprehensive efficacy and representing the pinnacle of the IP2 and IP5 iterations. This product employs a fully saturated molecular optimization process to achieve 100% saturated binding to the GHS-R1a receptor, maximizing molecular anti-degradation stability and achieving peak pulsed growth hormone activity output. Continuing the series' core advantage of ultra-high selectivity, this product can precisely induce physiological growth hormone pulsed secretion without increasing cortisol or prolactin levels, completely eliminating non-specific hormone interference. With its industry-leading 10mg concentration, this product is perfectly suited for ultra-high dose gradient limit studies, ultra-long-term growth hormone axis homeostasis interventions, enhanced body composition remodeling, and validation of high-standard peptide complex synergistic mechanisms. It is a top-tier core research ingredient for cutting-edge endocrinology and high-threshold preclinical metabolic research.

Cor